
MicroPredictome offers at-home tests that use a person’s gut microbiome to detect and triage gastrointestinal diseases in simple, actionable terms. The company sequences stool microbial profiles and applies machine learning and genetics-informed models to identify diagnostic signals for GI conditions. Its product sits at the intersection of consumer diagnostics and clinical-grade testing, positioning MicroPredictome in the DTC medical diagnostics and medtech categories. The platform relies on microbiome sequencing, AI/ML models, and human genetics data to generate results intended to reduce time-to-diagnosis and broaden access to precise GI care.

MicroPredictome offers at-home tests that use a person’s gut microbiome to detect and triage gastrointestinal diseases in simple, actionable terms. The company sequences stool microbial profiles and applies machine learning and genetics-informed models to identify diagnostic signals for GI conditions. Its product sits at the intersection of consumer diagnostics and clinical-grade testing, positioning MicroPredictome in the DTC medical diagnostics and medtech categories. The platform relies on microbiome sequencing, AI/ML models, and human genetics data to generate results intended to reduce time-to-diagnosis and broaden access to precise GI care.